Nov 3, 2023 8:00 am EDT Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
Oct 19, 2023 4:30 pm EDT Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
Sep 25, 2023 4:05 pm EDT Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
Sep 21, 2023 8:00 am EDT Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
Sep 19, 2023 4:45 pm EDT Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference